Anjalee Khemlani's profile photo

Anjalee Khemlani

New York

Senior Health Reporter at Yahoo Finance

Senior Health Reporter @ Yahoo Finance 'Information is my oxygen'

Featured in: Favicon yahoo.com (+15) Favicon msn.com Favicon aol.com Favicon governing.com Favicon pressofatlanticcity.com Favicon latinpost.com Favicon newslanes.com Favicon njbiz.com Favicon roi-nj.com Favicon intellasia.net

Articles

  • Healthcare worst-performing S&P sub-sector YTD: Mizuho expert

    1 day ago | finance.yahoo.com | Anjalee Khemlani

    The healthcare sector is not doing so well. It's been a key target of the Trump administration since the start of the year, and the headwinds keep coming.

  • How the UnitedHealth leadership shake-up is giving Wall Street the chills

    1 day ago | finance.yahoo.com | Anjalee Khemlani

    Wall Street is wary of UnitedHealth Group's (UNH) near-term prospects after the company's sudden CEO shake-up and its pulling of 2025 financial guidance on Tuesday. Bank of America Securities, for one, downgraded the stock to Neutral. "We view the decision to pull the 2025 guide as a combination of uncertainty around ...

  • $2.2 billion for biotech Sapterna

    1 day ago | finance.yahoo.com | Anjalee Khemlani

    Novo Nordisk (NVO) announced a new $2.2 billion deal with San Francisco-based biotech Sapterna (SEPN) for obesity pills — the latest in a series of moves by the Danish drugmaker as it hopes to maintain its position as one of two leaders in the hot obesity market.

  • $2.2 billion for biotech Septerna

    1 day ago | ca.finance.yahoo.com | Anjalee Khemlani

    Novo Nordisk (NVO) announced a new $2.2 billion deal with San Francisco-based biotech Septerna (SEPN) for obesity pills — the latest in a series of moves by the Danish drugmaker as it hopes to maintain its position as one of two leaders in the hot obesity market.

  • UnitedHealth Group stock sinks as CEO steps down, company suspends guidance

    2 days ago | finance.yahoo.com | Anjalee Khemlani

    UnitedHealth Group (UNH) CEO Andrew Witty, 60, stepped down from his role for "personal reasons" Tuesday, and the company is suspending its 2025 guidance. Former CEO Stephen Hemsley, 72, is taking the helm. UnitedHealth stock sank more than 15% in trading Tuesday, marking the company's latest negative day in an over 35% year-to-date plunge. NYSE - Nasdaq Real Time Price • USD As of 12:45:36 PM EDT. Market Open.

Contact details

Emails

[email protected]

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →

X (formerly Twitter)

Followers
9K
Tweets
22K
DMs Open
Yes
Anjalee Khemlani
Anjalee Khemlani @AnjKhem
15 May 25

RT @Reuters_Health: Sanofi plans to invest at least $20 billion in the United States through 2030 to boost manufacturing and research, join…

Anjalee Khemlani
Anjalee Khemlani @AnjKhem
14 May 25

2 former FDA Commissioners today, concerned about Trump admin health strategy: Califf: https://t.co/eHWGcSKixt Gottlieb: https://t.co/xCMHEf722q

Squawk Box
Squawk Box @SquawkCNBC

“I think the cumulative effect of all of these policies is that you’re going to see a wave of consolidation in the pharmaceutical sector,” says @ScottGottliebMD of the administration’s recent announcements in health care. https://t.co/pmB2E6ur3k

Anjalee Khemlani
Anjalee Khemlani @AnjKhem
14 May 25

RT @YahooFinance: Healthcare worst-performing S&P sub-sector YTD: Mizuho expert https://t.co/GgXPL6mqiG by @AnjKhem